GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

Sector Update: Health Care Stocks Fall Late Afternoon — Sep 25th, 2024

Sector Update: Health Care Stocks Fall Late Afternoon...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

Sector Update: Health Care Stocks Fall Late Afternoon — Sep 25th, 2024

Sector Update: Health Care Stocks Fall Late Afternoon...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat — Oct 3rd, 2024

GigaGen, Inc. The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s recombinant polyclonals are part of Grifols’ robust innovation strategy and ...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

High Growth Tech Stocks To Watch In October 2024 — Oct 3rd, 2024

As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and...

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say — Sep 30th, 2024

By Andres Gonzalez LONDON (Reuters) - Canadian fund Brookfield reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday. Brookfield sent a l...